This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Retinopathy of Prematurity (ROP)
and you are
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to compare the dilating effect of 0, 1, 2 or 3 drops of mydriatic (pupil dilating) in premature infants undergoing routine retinal (eye) screening exams for Retinopathy of Prematurity (ROP).

Provided treatments

  • Drug: 1% phenylephrine and 0.2% cyclopentolate

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01054027. The sponsor of the trial is Georgetown University and it is looking for 15 volunteers for the current phase.
Official trial title:
A Randomized Controlled Trial to Determine the Lowest Effective Dose for Adequate Mydriasis in Premature Infants